P. M. Bell
Royal Victoria Regional Health Centre
15 Papers
107 Citations
P. M. Bell is an academic researcher from Royal Victoria Regional Health Centre. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 9, co-authored 15 publications.
Chat about Author
Papers
Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial
TL;DR: The effect of the antioxidant vitamin E on endothelial function, insulin action and cardiovascular risk markers in young healthy adult offspring of parents with Type 2 diabetes is determined.
47
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
TL;DR: This work investigated the acute effects of metformin with and without food on DPP‐4 activity in Type 2 diabetes.
46
Demonstration of increased concentrations of circulating glycated insulin in human Type 2 diabetes using a novel and specific radioimmunoassay
TL;DR: A novel and specific radioimmunoassay is used to detect glycated insulin in plasma of Type 2 diabetic subjects and circulates at noticeably increased concentrations in Type 2 diabetes subjects.
Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation
Aine McKillop,Nicola A. Duffy,John R. Lindsay,Brian D. Green,Steven Patterson,Finbarr O'Harte,P. M. Bell,Peter R. Flatt +7 more
TL;DR: The possibility that some of the beneficial actions of nateglinide are indirectly mediated through DPP-IV inhibition and increased bioavailability of GIP and other incretins merits consideration.
Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study.
TL;DR: The effects on insulin sensitivity of captopril either alone or in combination with bendrofluazide in 11 hypertensive Type 2 diabetic patients was examined.
17